Ritu Shah
Vorstandsvorsitzender bei ClostraBio, Inc.
Profil
Ritu Shah is currently the Chief Executive Officer at ClostraBio, Inc. and the Managing Director at Portal Innovations LLC.
Previously, she held the position of Vice President-Program Management at Novartis Gene Therapies, Inc. from 2017 to 2018 and VP-Business Operations & Program Management at Levo Therapeutics, Inc. from 2018 to 2021.
She also served as the Chief Operating Officer at Pyxis Oncology, Inc. Ms. Shah completed her undergraduate degree at the University of Notre Dame.
Aktive Positionen von Ritu Shah
| Unternehmen | Position | Beginn |
|---|---|---|
ClostraBio, Inc.
 ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Vorstandsvorsitzender | 24.01.2023 |
Portal Innovations LLC
 Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 01.12.2022 |
Ehemalige bekannte Positionen von Ritu Shah
| Unternehmen | Position | Ende |
|---|---|---|
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Corporate Officer/Principal | 01.03.2021 |
| AVEXIS INC | Corporate Officer/Principal | 01.07.2018 |
| PYXIS ONCOLOGY, INC. | Geschäftsführer | - |
Ausbildung von Ritu Shah
| University of Notre Dame | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Finance |
